Eterna Therapeutics
ERNA
#11171
Rank
C$3.3 M
Marketcap
C$1.95
Share price
-16.56%
Change (1 day)
2.46%
Change (1 year)

Earnings for Eterna Therapeutics (ERNA)

Earnings in 2026 (TTM): -C$22.96 Million

According to Eterna Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$20.23 Million, an increase over its 2024 earnings that were of -C$54.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eterna Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$22.96 Million13.5%
2025 -C$20.23 Million-62.78%
2024 -C$54.34 Million84.63%
2023 -C$29.44 Million-16.24%
2022 -C$35.14 Million-80.08%
2021 -C$0.18 Billion1596.7%
2020 -C$10.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
C$11.16 B-47,243.04%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-C$0.27 Billion 1,031.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
C$22.91 M-196.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-C$27.31 Million 15.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-C$5.55 Million-76.61%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
C$1.75 B-7,509.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
C$0.35 B-1,615.19%๐Ÿ‡บ๐Ÿ‡ธ USA